|
Intersecting Biological and Chemical Knowledge for Computational Toxicology
02 October 2009
Florian Nigsch, Research Associate, University of Cambridge, speaking at ADMET Europe 2009
|
|
|
|
Bioluminescent Cytochrome P450 Inhibition and Induction Assays: Comparisons to Conventional Methods
18 August 2009
Jim Cali, Senior Scientist, Promega, speaking at ADMET Europe 2009
|
|
|
|
In silico Prediction of ADMET Properties
18 August 2009
John Dearden, School of Pharmacy and Chemistry, Liverpool John Moores University, speaking as ADMET Europe 2009
|
|
|
|
Retigabine and Therapeutic Indications of Activating Neuronal KCNQ Voltage-Gated Potassium Ion Channels
25 June 2009
Jim Wu, Head of Discovery Biology, Roche R&D Center, speaking at Ion Channel Targets 2008
|
|
|
|
Hypertension in P2Y2 Receptor-Deficient Mice is Caused by Constitutive Activation of ENaC
25 June 2009
James Stockand, Associate Professor, University of Texas Health Science Center at Houston, speaking at Ion Channel Targets 2008
|
|
|
|
Mechanosensitivity, A Wide Open Field
19 June 2009
Frederick Sachs, Distinguished Professor, New York State University at Buffalo, speaking at Ion Channel Targets 2008
|
|
|
|
Novel Recombinant Peptide Toxin Fusion Proteins as Potential Therapeutics for the Treatment of Autoimmune Disease
19 June 2009
Hung Nguyen, Principal Scientist, Amgen, speaking at Ion Channel Targets 2008
|
|
|
|
Chemogenomics in Drug Discovery
08 May 2009
Hugo Kubinyi, Retired Professor, Pharmaceutical Chemistry, University of Heidelberg, speaking at MedChem Europe 2009
|
|
|
|
Prediction of Drug-Drug Interactions Caused by Metabolism-Based Inhibition of Cytochrome P450 Using a Mechanistic Static Model: The Weak & Missing Links?
15 April 2009
Olivier Barberan, Director of Product Development, AUREUS-Pharma, speaking at ADMET Europe 2009
|
|
|
|
Ion Channel Panels for Safety Assessment and Drug Discovery
03 April 2009
Arthur "Buzz" Brown, President & CEO, ChanTest Corporation, speaking at Ion Channel Targets 2008
|
|
|
|
Chemical Activation of Voltage-Gated Potassium Channels
03 April 2009
Min Li, Professor, Department of Neuroscience & High Throughput Biology Center, Johns Hopkins School of Medicine, speaking at Ion Channel Targets 2008
|
|
|
|
In silico ADMET Traffic Lights and PhysChem Scores and Their Application to Kinase Inhibitors
06 February 2008
Mario Lobell, Computational Chemist, Bayer HealthCare, speaking at Virtual Discovery, 2007
|
|
|
|
Virtual Screening in Lead Discovery
10 January 2008
Hugo Kubinyi, Professor of Pharmaceutical Chemistry, University of Heidelberg, speaking at Virtual discovery 2007
|
|
|
|
The Way to Safety Biomarkers: Holy Grail of Toxicology
13 December 2007
Thomas Herget, Director New Technology Evaluation, Division Chemicals R&D, Merck, speaking at the European Biomarkers Summit, 2007
|
|
|
|
Quintessential Electrophysiology: ICRAC Recordings on the Q-Patch
12 February 2007
Dr. Dayne Okuhara, Synta Pharmaceuticals speaking at Ion Channel Targets 2006.
|
|
|
|
Safety Testing of the Human Cardiac Sodium Channel with PatchXpress
01 February 2007
Nathan Lautermilch, MDS Pharma Services speaking at Ion Channel Targets 2006.
|
|
|
|
The Development of Ion Channel Screening Assays for use in Drug Development
01 February 2007
Ray Helliwell, Millipore speaking at Ion Channel Targets 2006.
|
|
|
|
High Content Screening for Pro-Apoptotic Compounds
03 August 2006
Prof. Stig Linder, Karolinska Institute, speaking at Screening Europe 2006.
|
|
|
|
Automated Ion Channel Drug Discovery: Evaluation of hERG Inhibitors
12 July 2006
Dr. Timm Danker, Application Specialist, Cytocentrics AG speaking at Screening Europe 2006.
|
|
|
|
Metabolomics as a Tool for Biomarker Discovery
12 May 2006
Dr. Chris Beecher, Vice President of Biochemistry and Technology, Metabolon, Inc., speaking at Advances in Metabolic Profiling 2005
|
|
|
|
HTS/HCS in the Context of Genetic Toxicology
28 March 2006
Dr. Richard Walmsley, University of Manchester and Gentronix Ltd. speaking at Screening Europe 2006.
|
|
|
|
Metabolic Profiles and Biomarkers for Detection and Prediction of Drug Effects
07 February 2006
Hans Senn of F. Hoffmann-La Roche AG speaking at Advances in Metabolic Profiling 2005.
|
|
|
|
Predicting the Safety of FDA Regulated Products with Metabolomics
07 February 2006
Laura Schnackenberg, Center for Metabolomics Research, speaks at Advances in Metabolic Profiling 2005.
|
|
|
|
HERG, Repolarization and Sudden Cardiac Death
13 January 2006
Arthur M. Brown, Chairman and CEO, ChanTest, Inc., speaks at Ion Channel Targets 2005.
|
|
|
|
Extracellular Field Potential Recording in Cardiac Myocyte Culture with the QT-Screen System
13 January 2006
Prof. Dr. Elke Guenther, Head of Electrophysiology, NMI Natural and Medical Sciences Institute, speaking at Screening Europe 2005.
|
|
|
|
hERG Screening: Ion Channel Cardiac Safety Pharmacology Using Whole-Cell Recordings in FlipTips
23 December 2005
Dr. Martin Traebert, Group Head of in vitro Safety Pharmacology in Preclinical Development, Novartis Pharma AG, speaking at Screening Europe 2005.
|
|
|